3-99818026-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_032359.4(CMSS1):c.47G>A(p.Gly16Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000638 in 1,613,876 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_032359.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CMSS1 | NM_032359.4 | c.47G>A | p.Gly16Glu | missense_variant | 1/10 | ENST00000421999.8 | |
HP09053 | NR_110821.1 | n.624C>T | non_coding_transcript_exon_variant | 3/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CMSS1 | ENST00000421999.8 | c.47G>A | p.Gly16Glu | missense_variant | 1/10 | 1 | NM_032359.4 | P1 | |
CMSS1 | ENST00000496116.1 | n.115G>A | non_coding_transcript_exon_variant | 1/5 | 1 | ||||
CMSS1 | ENST00000463526.1 | c.-131G>A | 5_prime_UTR_variant | 1/4 | 3 | ||||
CMSS1 | ENST00000491299.5 | c.47G>A | p.Gly16Glu | missense_variant, NMD_transcript_variant | 1/9 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152262Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000100 AC: 25AN: 249870Hom.: 0 AF XY: 0.000162 AC XY: 22AN XY: 135466
GnomAD4 exome AF: 0.0000643 AC: 94AN: 1461496Hom.: 0 Cov.: 30 AF XY: 0.0000921 AC XY: 67AN XY: 727084
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152380Hom.: 0 Cov.: 33 AF XY: 0.000107 AC XY: 8AN XY: 74520
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 13, 2023 | The c.47G>A (p.G16E) alteration is located in exon 1 (coding exon 1) of the CMSS1 gene. This alteration results from a G to A substitution at nucleotide position 47, causing the glycine (G) at amino acid position 16 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at